• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂将气道和肺泡中的颗粒驱向上皮细胞。

Surfactant displaces particles toward the epithelium in airways and alveoli.

作者信息

Schürch S, Gehr P, Im Hof V, Geiser M, Green F

机构信息

Respiratory Research Group, University of Calgary, Alberta, Canada.

出版信息

Respir Physiol. 1990 Apr;80(1):17-32. doi: 10.1016/0034-5687(90)90003-h.

DOI:10.1016/0034-5687(90)90003-h
PMID:2367749
Abstract

This study was designed to investigate the early stages of particle deposition on airway and alveolar surfaces. To do this we used morphometric studies of aerosol deposition, in situ measurements of surface tension, and in vitro assays of particle displacement and mathematical modelling. We observed that latex particles, equal or less than 6 microns in diameter deposited in hamster lungs were submerged in the subphase of the alveolar lining layer and became completely coated with an osmiophilic film. Similar results were obtained for particles deposited in the conductive airways which were also covered with a surface active film, having a surface tension of 32 +/- 2 dyn.cm-1. In vitro experiments showed that pulmonary surfactant promotes the displacement of particles from air to the aqueous phase and that the extent of particle immersion depends on the surface tension of the surface active film. The lower the surface tension the greater is the immersion of the particles into the aqueous subphase. Mathematical analysis of the forces acting on a particle deposited on an air-fluid interface show that for small particles (less than 100 microns) the surface tension force is several orders of magnitude greater than forces related to gravity. Thus, even at the relatively high surface tension obtained in the airways (32 +/- 2 dyn.cm-1) particles will still be displaced into the aqueous subphase. Particles in peripheral airways and alveoli likely are below the surfactant film and submerged in the subphase. This may promote clearance by macrophages. In addition, particle displacement into the subphase is likely to increase the contact between the epithelial cell and particle. Toxic or allergenic particles would be available to interact with epithelial cells and this may be important in the pathophysiology of airway disease.

摘要

本研究旨在调查颗粒在气道和肺泡表面沉积的早期阶段。为此,我们采用了气溶胶沉积的形态计量学研究、表面张力的原位测量、颗粒位移的体外测定以及数学建模。我们观察到,直径等于或小于6微米的乳胶颗粒沉积在仓鼠肺中后,会浸没在肺泡衬里层的亚相中,并完全被一层嗜锇膜覆盖。沉积在传导气道中的颗粒也得到了类似的结果,这些颗粒同样被一层表面活性膜覆盖,其表面张力为32±2达因·厘米⁻¹。体外实验表明,肺表面活性剂促进颗粒从气相转移到水相,并且颗粒的浸没程度取决于表面活性膜的表面张力。表面张力越低,颗粒浸入水相亚相的程度就越大。对作用于沉积在气液界面上的颗粒的力进行数学分析表明,对于小颗粒(小于100微米),表面张力力比与重力相关的力大几个数量级。因此,即使在气道中获得的相对较高的表面张力(32±2达因·厘米⁻¹)下,颗粒仍会被转移到水相亚相中。外周气道和肺泡中的颗粒可能位于表面活性剂膜下方并浸没在亚相中。这可能会促进巨噬细胞的清除作用。此外,颗粒转移到亚相中可能会增加上皮细胞与颗粒之间的接触。有毒或致敏颗粒可能会与上皮细胞相互作用,这在气道疾病的病理生理学中可能很重要。

相似文献

1
Surfactant displaces particles toward the epithelium in airways and alveoli.表面活性剂将气道和肺泡中的颗粒驱向上皮细胞。
Respir Physiol. 1990 Apr;80(1):17-32. doi: 10.1016/0034-5687(90)90003-h.
2
Surfactant and inhaled particles in the conducting airways: structural, stereological, and biophysical aspects.传导气道中的表面活性剂和吸入颗粒:结构、体视学和生物物理学方面
Microsc Res Tech. 1993 Dec 1;26(5):423-36. doi: 10.1002/jemt.1070260510.
3
Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer.颗粒的表面化学性质和形貌对其浸入肺表面衬里层的影响。
J Appl Physiol (1985). 2003 May;94(5):1793-801. doi: 10.1152/japplphysiol.00514.2002. Epub 2003 Jan 24.
4
Retention of Teflon particles in hamster lungs: a stereological study.
J Aerosol Med. 2000 Spring;13(1):43-55. doi: 10.1089/jam.2000.13.43.
5
Influence of airspace geometry and surfactant on the retention of man-made vitreous fibers (MMVF 10a).气腔几何形状和表面活性剂对人造玻璃纤维(MMVF 10a)滞留的影响。
Environ Health Perspect. 2003 Jun;111(7):895-901. doi: 10.1289/ehp.5888.
6
Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.传导气道表面活性剂:表面张力功能、生化组成及可能的肺泡起源。
Am J Respir Cell Mol Biol. 1997 Jul;17(1):41-50. doi: 10.1165/ajrcmb.17.1.2594.
7
[The mucociliary system of the lung--role of surfactants].[肺的黏液纤毛系统——表面活性剂的作用]
Schweiz Med Wochenschr. 2000 May 13;130(19):691-8.
8
Formation and structure of surface films: captive bubble surfactometry.表面膜的形成与结构:俘获气泡表面张力测定法
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):180-202. doi: 10.1016/s0925-4439(98)00067-2.
9
[Particle retention in the intrapulmonary conducting airways in hamsters].[仓鼠肺内传导气道中的颗粒滞留]
Schweiz Med Wochenschr. 1990 Oct 13;120(41):1497-503.
10
Ultrastructure of the aqueous lining layer in hamster airways: is there a two-phase system?仓鼠气道水液层的超微结构:是否存在双相系统?
Microsc Res Tech. 1997 Mar 1;36(5):428-37. doi: 10.1002/(SICI)1097-0029(19970301)36:5<428::AID-JEMT13>3.0.CO;2-U.

引用本文的文献

1
Targeting Immune Cells.靶向免疫细胞。
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):328-337. doi: 10.1089/jamp.2024.63954.es.
2
Effects of Kinematic Hardening of Mucus Polymers in an Airway Closure Model.气道闭合模型中黏液聚合物运动硬化的影响
J Nonnewton Fluid Mech. 2024 Aug;330. doi: 10.1016/j.jnnfm.2024.105281. Epub 2024 Jun 24.
3
The pathogenesis of influenza in intact alveoli: virion endocytosis and its effects on the lung's air-blood barrier.完整肺泡中流感的发病机制:病毒粒子内吞作用及其对肺气血屏障的影响。
Front Immunol. 2024 Jan 26;15:1328453. doi: 10.3389/fimmu.2024.1328453. eCollection 2024.
4
New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome.肺泡上皮作为急性呼吸窘迫综合征驱动因素的新见解。
Biomolecules. 2022 Sep 10;12(9):1273. doi: 10.3390/biom12091273.
5
Developing inhaled protein therapeutics for lung diseases.开发用于肺部疾病的吸入性蛋白质疗法。
Mol Biomed. 2020;1(1):11. doi: 10.1186/s43556-020-00014-z. Epub 2020 Oct 30.
6
Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.健康与患病人类呼吸道的气液界面培养:前景、挑战与未来方向。
Adv Nanobiomed Res. 2021 May 6;1(6). doi: 10.1002/anbr.202000111. eCollection 2021 Jun.
7
Inhaled aerosols: Their role in COVID-19 transmission, including biophysical interactions in the lungs.吸入气雾剂:它们在新冠病毒传播中的作用,包括在肺部的生物物理相互作用。
Curr Opin Colloid Interface Sci. 2021 Aug;54:101451. doi: 10.1016/j.cocis.2021.101451. Epub 2021 Mar 24.
8
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.用于阻塞性气道疾病的吸入式RNA疗法:最新进展与未来前景
Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177.
9
Interactions of particulate matter and pulmonary surfactant: Implications for human health.颗粒物与肺表面活性剂的相互作用:对人类健康的影响。
Adv Colloid Interface Sci. 2020 Oct;284:102244. doi: 10.1016/j.cis.2020.102244. Epub 2020 Aug 19.
10
Drug Delivery Properties of Nanocomposite Particles for Inhalation: Comparison of Drug Concentrations in Lungs and Blood.吸入用纳米复合粒子的药物传递特性:肺部和血液中的药物浓度比较。
In Vivo. 2020 Mar-Apr;34(2):543-547. doi: 10.21873/invivo.11806.